What Arthritis Patients Should Know About Biologics

In the late 1990s, the first of several biologics went on the market to treat rheumatoid arthritis. The first was Enbrel (etanercept) -- but it did not take long for other biologics to be developed and marketed. Biologics target molecules on cells of the immune system, joint, and the products that are secreted in the joint, all of which can cause inflammation and joint destruction.

Who should use biologics? Perhaps even more importantly, who should not use biologics? If you decide biologics are for you, what helps you decide which biologic to try? Learn more in What Arthritis Patients Should Know About Biologics?

Related Resources:

• TNF Blockers - What You Need to Know
• Orencia for Rheumatoid Arthritis
• The Facts of Rituxan
• Simponi - What You Should Know
• Are Some Arthritis Patients Unsuitable Candidates for Biologics?

Join the Discussion:

• Join Us in Our Arthritis Forum / Message Board

_{Photo by Zhe Zhang (stock.xchng)}